Naoya Fujita

ORCID: 0000-0002-5097-1353
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal Diseases and Glomerulopathies
  • Dialysis and Renal Disease Management
  • Chronic Kidney Disease and Diabetes
  • Cardiac Imaging and Diagnostics
  • Cardiovascular Function and Risk Factors
  • Pediatric Urology and Nephrology Studies
  • Platelet Disorders and Treatments
  • Renal Transplantation Outcomes and Treatments
  • Muscle and Compartmental Disorders
  • Birth, Development, and Health
  • Escherichia coli research studies
  • Blood Pressure and Hypertension Studies
  • Coronary Interventions and Diagnostics
  • Vascular anomalies and interventions
  • Genetic and Kidney Cyst Diseases
  • Viral gastroenteritis research and epidemiology
  • Systemic Lupus Erythematosus Research
  • Cardiomyopathy and Myosin Studies
  • Renal and Vascular Pathologies
  • Pulmonary Hypertension Research and Treatments
  • Cardiac Valve Diseases and Treatments
  • Urological Disorders and Treatments
  • Immune Cell Function and Interaction
  • Pregnancy and Medication Impact
  • Nitric Oxide and Endothelin Effects

Children's Medical Center
2012-2022

Kyoto Institute of Technology
2022

Japan Pediatric Society
2014

Seirei Hamamatsu General Hospital
2008-2014

Saiseikai Yokohama Eastern Hospital
2007

Toyohashi Municipal Hospital
2005

Nagoya City University
2005

Mizuho (Japan)
2005

Shiga University of Medical Science
1997

University of California, San Francisco
1992-1994

Significance Statement Rituximab is the standard therapy for childhood-onset complicated frequently relapsing or steroid-dependent nephrotic syndrome (FRNS/SDNS). However, most patients redevelop FRNS/SDNS after peripheral B cell recovery. This multicenter, randomized, double-blind, placebo-controlled trial was conducted to examine whether mycophenolate mofetil (MMF) administration rituximab can prevent treatment failure (FRNS, SDNS, steroid resistance, use of immunosuppressive agents...

10.1681/asn.2021050643 article EN Journal of the American Society of Nephrology 2021-12-08

Abstract Objectives: To assess the myocardium‐reperfusing effect of a distal protection device, GuardWire Plus™ (GuardWire Plus), in patients with acute myocardial infarction (AMI). Background: Distal embolization may result reduced perfusion, increasing risk non‐Q‐wave and death. devices protect microcirculation from embolic debris, improving short‐ long‐term clinical outcomes. Methods: From February 2002 to July 2003, total 341 AMI at 22 institutions Japan were enrolled present,...

10.1002/ccd.21190 article EN Catheterization and Cardiovascular Interventions 2007-07-09

Abstract Background The assessment of kidney size is essential for treating disease. However, there are no reliable and sufficiently robust ultrasonographic reference values or prediction formulas length in Japanese children, based on a sufficient number participants. Methods We retrospectively analyzed measurements by ultrasonography children aged 18 years younger from eight facilities throughout Japan between January 1991 September 2018. Detailed were developed aggregating the left right...

10.1007/s10157-022-02205-0 article EN cc-by Clinical and Experimental Nephrology 2022-04-16

Abnormal flow velocity curves across the tricuspid valve (TV) and in superior vena cava have been described patients with abnormal right ventricular (RV) relaxation or restriction pericardial diseases by means of Doppler echocardiography. In this study, various imaging planes strategies velocity-encoded cine (VEC) MR for measurement peak E A velocities E/A ratio TV were evaluated compared to measurements 10 normal volunteers. addition, VEC-MR performed cava. Peak derived from...

10.1097/00004728-199303000-00013 article EN Journal of Computer Assisted Tomography 1993-03-01

Abstract Background Developmental programming of chronic kidney disease (CKD) in young adults is linked to preterm birth and intrauterine growth restriction (IUGR). Which confers a higher risk progression damage children with very low weight (VLBW; born weighing < 1500 g): prematurity or IUGR? Methods This national historical cohort study VLBW cared for perinatal medical centers Japan. Predictive factors included three latent variables (prematurity, IUGR, stress during neonatal period)...

10.1007/s00467-020-04791-1 article EN cc-by Pediatric Nephrology 2020-10-17

Abstract Pierson syndrome (OMIM 609049) is typically characterized by congenital nephritic and peculiar ocular anomalies with microcoria. It caused mutations in LAMB2 , which encodes laminin β2. Approximately 50 of from approximately 40 unrelated families have been identified; however, most them were Western countries. Although three patients Asia reported, they not typical cases. We report the first Japanese case proven causative mutations. She presented nephrotic bilateral microcoria at...

10.1111/j.1442-200x.2012.03629.x article EN Pediatrics International 2013-04-01
Coming Soon ...